Patent ReferencesMethod for the direct analysis of sickle cell anemia Patent #: 4395486 InventorsAssigneeApplicationNo. 06/828144 filed on 02/07/1986US Classes:435/6, Involving nucleic acid435/91.2, Acellular exponential or geometric amplification (e.g., PCR, etc.)435/91.41, By insertion or addition of one or more nucleotides436/501, BIOSPECIFIC LIGAND BINDING ASSAY436/508, Antinuclear (e.g., DNA, etc.)436/63, BIOLOGICAL CELLULAR MATERIAL TESTED436/94Saccharide (e.g., DNA, etc.)ExaminersPrimary: Martinell, JamesAttorney, Agent or FirmInternational ClassesC12Q 1/68 (20060101)C12Q 1/68 (20060101) AbstractThe present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction may be carried out stepwise or simultaneously and can be repeated as often as desired.In addition, a specific nucleic acid sequence may be cloned into a vector by using primers to amplify the sequence, which contain restriction sites on their non-complementary ends, and a nucleic acid fragment may be prepared from an existing shorter fragment using the amplification process.Other References
|
| ||||||||||||||